Document is current
Any future updates will be listed below
-
Authors
Funk, Grahmm A. https://orcid.org/0000-0002-9594-4340
Menuey, Elizabeth M. https://orcid.org/0009-0006-9648-7803
Denton, Zachary D. https://orcid.org/0009-0006-5862-6243
Pittz, Dalan M. https://orcid.org/0009-0000-0641-9417
Parrales, Alejandro
Iwakuma, Tomoo https://orcid.org/0000-0001-7249-7958
Kilway, Kathleen V. https://orcid.org/0000-0002-5505-8619
McIff, Terence E. https://orcid.org/0000-0002-7481-2787
-
Funding
Funding for this research was provided by:
NIH (R01 CA214916)
Braden's Hope For Childhood Cancer
Kansas Masonic Alliance
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 5 December 2025
First Online: 26 December 2025
Compliance with ethical standards
:
: Kathleen V. Kilway holds a US patent on the formulation of the Silorane-based biomaterial used in the study. No other related conflicts of interest.
